Rifampicin vs MemeCore

MemeCore (M) is 10319.8× the size of Rifampicin ($RIF) by market capitalisation. Over the past 30 days, $RIF is ahead by 0.5 percentage points ($RIF -26.8% against M -27.3%). Their daily returns move barely in opposite directions (correlation -0.15 across 24 shared trading days). M has been the more volatile of the two, at 108% annualised against $RIF's 55%.

Correlation: -0.15
Size ratio: 1 : 10319.8
Ahead over 30 days: $RIF

Rifampicin$RIF

$0.000185

24h: +2.57%
Market cap: $185,245
Volume 24h: $615
Volatility (ann.): 55%

MemeCoreM

$0.833245

24h: -2.02%
Market cap: $1.91B
Volume 24h: $713,205
Volatility (ann.): 108%

$RIF 0.0%Share of the two combined market caps100.0% M

Performance

$RIFM

7 days-6.71%-19.79%$RIF
30 days-26.79%-27.25%$RIF

Correlation

-0.15over 24 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: insufficient data90d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	$RIF	M
Max drawdown (400d)	-32.5%	-41.1%
Risk-adjusted return (90d)	-0.45	-0.25

Relative strength over 90 days: M outperformed $RIF by 10.0% — measured on the $RIF/M ratio, so it holds regardless of market direction.

Rifampicin →MemeCore →